|
C4ORF36 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.03540000035474E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74249999999043E-05 |
| Normal-vs-Stage2 |
4.998500E-04 |
| Normal-vs-Stage3 |
1.413460E-04 |
| Normal-vs-Stage4 |
4.33889999484904E-08 |
| Stage1-vs-Stage2 |
9.031800E-01 |
| Stage1-vs-Stage3 |
8.258400E-01 |
| Stage1-vs-Stage4 |
2.344400E-02 |
| Stage2-vs-Stage3 |
7.925800E-01 |
| Stage2-vs-Stage4 |
1.524400E-01 |
| Stage3-vs-Stage4 |
3.539800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39169999999289E-05 |
| Normal-vs-AfricanAmerican |
4.800100E-04 |
| Normal-vs-Asian |
5.82359999999893E-05 |
| Caucasian-vs-AfricanAmerican |
2.733400E-01 |
| Caucasian-vs-Asian |
3.373400E-01 |
| AfricanAmerican-vs-Asian |
7.267600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52019999999364E-06 |
| Normal-vs-Female |
2.86910000002472E-06 |
| Male-vs-Female |
5.944200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.27900000000703E-05 |
| Normal-vs-Age(41-60Yrs) |
9.85939999975649E-07 |
| Normal-vs-Age(61-80Yrs) |
2.88950000004728E-06 |
| Normal-vs-Age(81-100Yrs) |
4.415600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.282400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.848800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.110800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.103000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.290200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.233400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.379600E-01 |
| Classical-VS-Follicular |
7.936200E-03 |
| Classical-VS-Other |
4.081600E-01 |
| Classical-VS-Normal |
9.56970000000057E-05 |
| Tall-VS-Follicular |
4.648200E-01 |
| Tall-VS-Other |
8.301600E-01 |
| Tall-VS-Normal |
4.08050000000326E-05 |
| Follicular-VS-Other |
9.548800E-01 |
| Follicular-VS-Normal |
4.04729999958775E-07 |
| Other-VS-Normal |
2.583800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92170000001823E-06 |
| Normal-vs-N1 |
1.7429299999927E-05 |
| N0-vs-N1 |
4.432200E-01 |
|
|
